CGEM Cullinan Therapeutics, Inc.
$14.81
Cullinan Therapeutics, Inc. (CGEM) Earnings News
Earnings press releases, previews and reviews for Cullinan Therapeutics, Inc. (CGEM), newest first.
Monday
September 14, 2026
7:00 AM ET
Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer
Thursday
September 10, 2026
1:00 PM ET
Cullinan Therapeutics to Host Virtual Analyst and Investor Event to Showcase Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer
Thursday
August 6, 2026
7:00 AM ET
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Thursday
May 7, 2026
7:00 AM ET
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results